These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 30629447)
1. Proteomics Analysis Reveals That Structural Proteins of the Virion Core and Involved in Gene Expression Are the Main Source for HLA Class II Ligands in Vaccinia Virus-Infected Cells. Lorente E; Martín-Galiano AJ; Barnea E; Barriga A; Palomo C; García-Arriaza J; Mir C; Lauzurica P; Esteban M; Admon A; López D J Proteome Res; 2019 Mar; 18(3):900-911. PubMed ID: 30629447 [TBL] [Abstract][Full Text] [Related]
2. Immunoproteomic analysis of a Chikungunya poxvirus-based vaccine reveals high HLA class II immunoprevalence. Lorente E; Barriga A; Barnea E; Palomo C; García-Arriaza J; Mir C; Esteban M; Admon A; López D PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007547. PubMed ID: 31276466 [TBL] [Abstract][Full Text] [Related]
3. The HLA-DP peptide repertoire from human respiratory syncytial virus is focused on major structural proteins with the exception of the viral polymerase. Lorente E; Barnea E; Mir C; Admon A; López D J Proteomics; 2020 Jun; 221():103759. PubMed ID: 32244010 [TBL] [Abstract][Full Text] [Related]
4. Acid Stripping after Infection Improves the Detection of Viral HLA Class I Natural Ligands Identified by Mass Spectrometry. Lorente E; Marcilla M; de la Sota PG; Quijada-Freire A; Mir C; López D Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638844 [TBL] [Abstract][Full Text] [Related]
5. Structural and Nonstructural Viral Proteins Are Targets of T-Helper Immune Response against Human Respiratory Syncytial Virus. Lorente E; Barriga A; Barnea E; Mir C; Gebe JA; Admon A; López D Mol Cell Proteomics; 2016 Jun; 15(6):2141-51. PubMed ID: 27090790 [TBL] [Abstract][Full Text] [Related]
6. Multiple viral ligands naturally presented by different class I molecules in transporter antigen processing-deficient vaccinia virus-infected cells. Lorente E; Infantes S; Barnea E; Beer I; García R; Lasala F; Jiménez M; Vilches C; Lemonnier FA; Admon A; López D J Virol; 2012 Jan; 86(1):527-41. PubMed ID: 22031944 [TBL] [Abstract][Full Text] [Related]
7. Vaccinia virus decreases major histocompatibility complex (MHC) class II antigen presentation, T-cell priming, and peptide association with MHC class II. Rehm KE; Connor RF; Jones GJ; Yimbu K; Mannie MD; Roper RL Immunology; 2009 Nov; 128(3):381-92. PubMed ID: 20067538 [TBL] [Abstract][Full Text] [Related]
8. Long-term immunity against actual poxviral HLA ligands as identified by differential stable isotope labeling. Meyer VS; Kastenmuller W; Gasteiger G; Franz-Wachtel M; Lamkemeyer T; Rammensee HG; Stevanovic S; Sigurdardottir D; Drexler I J Immunol; 2008 Nov; 181(9):6371-83. PubMed ID: 18941228 [TBL] [Abstract][Full Text] [Related]
9. HIV-1 proteins in infected cells determine the presentation of viral peptides by HLA class I and class II molecules and the nature of the cellular and humoral antiviral immune responses--a review. Becker Y Virus Genes; 1994 Jul; 8(3):249-70. PubMed ID: 7975271 [TBL] [Abstract][Full Text] [Related]
10. Human FAM111A inhibits vaccinia virus replication by degrading viral protein I3 and is antagonized by poxvirus host range factor SPI-1. Zhu J; Gao X; Li Y; Zhang Z; Xie S; Ren S; Li Y; Li H; Niu K; Fu S; Deng Y; Li Y; Moss B; Wu W; Peng C Proc Natl Acad Sci U S A; 2023 Aug; 120(35):e2304242120. PubMed ID: 37607234 [TBL] [Abstract][Full Text] [Related]
11. Immunopeptidomic analysis of influenza A virus infected human tissues identifies internal proteins as a rich source of HLA ligands. Nicholas B; Bailey A; Staples KJ; Wilkinson T; Elliott T; Skipp P PLoS Pathog; 2022 Jan; 18(1):e1009894. PubMed ID: 35051231 [TBL] [Abstract][Full Text] [Related]
12. Vaccinia Virus A6 Is a Two-Domain Protein Requiring a Cognate N-Terminal Domain for Full Viral Membrane Assembly Activity. Meng X; Rose L; Han Y; Deng J; Xiang Y J Virol; 2017 May; 91(10):. PubMed ID: 28275183 [TBL] [Abstract][Full Text] [Related]
13. Discovery of naturally processed and HLA-presented class I peptides from vaccinia virus infection using mass spectrometry for vaccine development. Johnson KL; Ovsyannikova IG; Mason CJ; Bergen HR; Poland GA Vaccine; 2009 Dec; 28(1):38-47. PubMed ID: 19822231 [TBL] [Abstract][Full Text] [Related]
14. Vaccinia virus-specific CD8(+) T-cell responses target a group of epitopes without a strong immunodominance hierarchy in humans. Terajima M; Orphin L; Leporati AM; Pazoles P; Cruz J; Rothman AL; Ennis FA Hum Immunol; 2008 Dec; 69(12):815-25. PubMed ID: 18955096 [TBL] [Abstract][Full Text] [Related]
15. Molecular analysis of HLA class II associations with hepatitis B virus clearance and vaccine nonresponsiveness. Godkin A; Davenport M; Hill AV Hepatology; 2005 Jun; 41(6):1383-90. PubMed ID: 15915462 [TBL] [Abstract][Full Text] [Related]
16. Selective reconstitution of IFN‑γ gene function in Ncr1+ NK cells is sufficient to control systemic vaccinia virus infection. Borst K; Flindt S; Blank P; Larsen PK; Chhatbar C; Skerra J; Spanier J; Hirche C; König M; Alanentalo T; Hafner M; Waibler Z; Pfeffer K; Sexl V; Sutter G; Müller W; Graalmann T; Kalinke U PLoS Pathog; 2020 Feb; 16(2):e1008279. PubMed ID: 32023327 [TBL] [Abstract][Full Text] [Related]
17. Genomic Analysis, Phenotype, and Virulence of the Historical Brazilian Smallpox Vaccine Strain IOC: Implications for the Origins and Evolutionary Relationships of Vaccinia Virus. Medaglia ML; Moussatché N; Nitsche A; Dabrowski PW; Li Y; Damon IK; Lucas CG; Arruda LB; Damaso CR J Virol; 2015 Dec; 89(23):11909-25. PubMed ID: 26378174 [TBL] [Abstract][Full Text] [Related]
18. Abundance, Betweenness Centrality, Hydrophobicity, and Isoelectric Points Are Relevant Factors in the Processing of Parental Proteins of the HLA Class II Ligandome. Lorente E; Martín-Galiano AJ; Kadosh DM; Barriga A; García-Arriaza J; Mir C; Esteban M; Admon A; López D J Proteome Res; 2022 Jan; 21(1):164-171. PubMed ID: 34937342 [TBL] [Abstract][Full Text] [Related]
19. Vaccinia Virus Protein C6: A Multifunctional Interferon Antagonist. Smith GL Adv Exp Med Biol; 2018; 1052():1-7. PubMed ID: 29785476 [TBL] [Abstract][Full Text] [Related]
20. Linear Epitopes in Vaccinia Virus A27 Are Targets of Protective Antibodies Induced by Vaccination against Smallpox. Kaever T; Matho MH; Meng X; Crickard L; Schlossman A; Xiang Y; Crotty S; Peters B; Zajonc DM J Virol; 2016 May; 90(9):4334-4345. PubMed ID: 26889021 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]